Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Current Neurology and Neuroscience Reports
Metadata
Title
Anti-inflammatory agents in Alzheimer’s disease
Author
Paul S. Aisen, MD
Publication date
01-10-2002
Publisher
Current Medicine Group
Published in
Current Neurology and Neuroscience Reports / Issue 5/2002
Print ISSN: 1528-4042
Electronic ISSN: 1534-6293
DOI
https://doi.org/10.1007/s11910-002-0066-6

Other articles of this Issue 5/2002

Current Neurology and Neuroscience Reports 5/2002 Go to the issue

Clinical Trials Report

Cholinesterase inhibitors in dementia

OriginalPaper

Prevention of Alzheimer’s disease: Where we stand

OriginalPaper

Chronic progressive external ophthalmoplegia

OriginalPaper

Parasellar syndromes

OriginalPaper

Immunization treatment approaches in Alzheimer’s and prion diseases

Abstract

Literature alert